Literature DB >> 15042126

High plasma arginine concentrations in critically ill patients suffering from hepatic failure.

R J Nijveldt1, M P C Siroen, B van der Hoven, T Teerlink, H A Prins, A R J Girbes, P A M van Leeuwen.   

Abstract

OBJECTIVE: In physiological conditions, the liver plays an important role in the regulation of plasma arginine concentrations by taking up large amounts of arginine from the hepatic circulation. When hepatic failure is present, arginine metabolism may be disturbed. Therefore, we hypothesized high arginine plasma concentrations in critically ill patients suffering from hepatic failure.
DESIGN: We prospectively collected blood samples from a cross-section of intensive care unit patients.
SETTING: Surgical intensive care unit of a Dutch university medical center.
SUBJECTS: A total of 52 critically ill patients with clinical evidence of dysfunction of more than two organs were recruited. MEASUREMENTS: Plasma arginine concentrations were determined by HPLC. We identified correlations of arginine concentrations with organ failure scores and laboratory variables by univariate and multiple regression analyses.
RESULTS: High plasma arginine concentrations were found in critically ill patients developing organ failure. Patients who were in the highest quartile of plasma arginine concentrations had significantly lower fibrinogen concentrations, higher lactic acid concentrations, and longer prothrombin time. Stepwise multiple regression analysis showed that concentrations of arginine were independently associated with the presence of hepatic failure (P=0.03) and renal failure (P=0.048). In addition, lactic acid proved to be an independent determinant of plasma arginine concentration (P=0.014).
CONCLUSIONS: Critically ill patients who suffer from hepatic failure have elevated plasma arginine concentrations. Additional arginine in the treatment of these patients can be harmful, and therefore should not be used as a standard nutritional regimen until further evaluation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15042126     DOI: 10.1038/sj.ejcn.1601851

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  4 in total

1.  Extracellular activation of arginase-1 decreases enterocyte inducible nitric oxide synthase activity during systemic inflammation.

Authors:  Keita Miki; Abhai Kumar; Runkuan Yang; Meaghan E Killeen; Russell L Delude
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-08-27       Impact factor: 4.052

Review 2.  Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model.

Authors:  Jiunn-Ming Sheen; Yu-Chieh Chen; You-Lin Tain; Li-Tung Huang
Journal:  Int J Mol Sci       Date:  2014-03-05       Impact factor: 5.923

Review 3.  Transport of L-Arginine Related Cardiovascular Risk Markers.

Authors:  Sofna Banjarnahor; Roman N Rodionov; Jörg König; Renke Maas
Journal:  J Clin Med       Date:  2020-12-08       Impact factor: 4.241

4.  Factors that influence the quality of metabolomics data in in vitro cell toxicity studies: a systematic survey.

Authors:  Marta Moreno-Torres; Guillem García-Llorens; Erika Moro; Rebeca Méndez; Guillermo Quintás; José Vicente Castell
Journal:  Sci Rep       Date:  2021-11-11       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.